Aurobindo Pharma, Lupin, DRL: Nifty Pharma Index Drops 2.52% Following Trump’s Tariff Proposal on Drug Imports
Stocks in the Nifty Pharma index were down by as much as 6% following US President Donald Trump's proposal to impose tariffs; ...